Military officials say it is safe, but some soldiers still worry about taking theanthrax vaccine. AFort Braggsoldier who refused the shot is now paying the price. TheU.S. Department of Defense ...

Emergent BioSolutions was awarded a 5-year, $235.8 million contract with the U.S. Department of Defense to supply the anthrax vaccine BioThrax to the various branches of the military. Under the terms ...

The US Food and Drug Administration (FDA) has repurposed a 45-year-old vaccine against anthrax for postexposure protection. Anthrax vaccine adsorbed (BioThrax, Emergency BioDefense Operations) was ...

Armed with a full FDA approval after four years of supplying its anthrax vaccine under a pre-emergency use authorization, Emergent BioSolutions is expanding its countermeasure supply pact with the ...

Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that could also open export markets for the new vaccine with fewer side effects, ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

In the autumn of 2001, following the terrorist attacks of September 11, anthrax and the anthrax vaccine became prominent national concerns. The deliberate distribution of anthrax spores through the ...